CHD8 Gene
Overview
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">CHD8 Gene</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>CHD8</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>CHD8</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Gene</td>
</tr>
<tr>
<td class="label">NCBI</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/?term=CHD8" target="_blank">Search NCBI</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
CHD8 (Chromodomain Helicase DNA Binding Protein 8, NCBI Gene ID: 57680, OMIM: 610527, UniProt: [Q9HCK8](https://www.uniprot.org/uniprot/Q9HCK8)) is a critical ATP-dependent chromatin remodeling factor and transcriptional regulator. As one of the largest members of the CHD (Chromodomain Helicase DNA-binding) family, CHD8 plays essential roles in neurodevelopment, Wnt/β-catenin signaling, and chromatin architecture maintenance. Heterozygous loss-of-function mutations in CHD8 are among the most common genetic causes of autism spectrum disorder (ASD), accounting for approximately 0.2% of all cases[@bernier2014]. Beyond its well-established role in neurodevelopmental disorders, emerging research suggests CHD8 dysfunction may contribute to neurodegenerative processes through epigenetic dysregulation, altered chromatin states, and impaired neuronal survival mechanisms[@plummer2023].
CHD8 functions by recruiting β-catenin (CTNNB1) to Wnt target gene promoters, thereby modulating the transcriptional programs that govern neural progenitor proliferation, cortical layer formation, and synaptic development[@katayama2016]. Its ability to reshape chromatin landscape affects hundreds of downstream targets including cell cycle regulators, synaptic proteins, and neurodevelopmental transcription factors[@noh2017].
Gene Structure and Protein Architecture
Genomic Organization
The human CHD8 gene spans approximately 197 kb on chromosome 14q11.2 and contains 37 coding exons. The gene encodes a 2,563 amino acid protein with a molecular weight of approximately 285 kDa. CHD8 is highly conserved across vertebrates, with orthologs in mouse (Chd8), zebrafish, and Drosophila.
Domain Architecture
CHD8 protein contains several distinct functional domains:
- Tandem chromodomains (amino acids 1-200): Two N-terminal chromodomains that bind methylated histone tails, particularly H3K4me0 and H3K9me3. These domains target CHD8 to specific chromatin regions.
- Snf2-like ATPase domain (amino acids 500-700): The central helicase domain that provides ATP-dependent chromatin remodeling activity. This domain belongs to the SWI/SNF2 family and hydrolyzes ATP to slide, eject, or restructure nucleosomes.
- DNA-binding domain (amino acids 750-900): Facilitates interaction with DNA during chromatin remodeling.
- BRK domain (amino acids 1850-1920): Present in some CHD family members, may mediate protein-protein interactions.
- C-terminal region: Contains glutamine-rich regions and potential transcriptional activation domains.
Transcript Variants
Multiple CHD8 transcript variants have been documented:
- Isoform 1 (canonical): Full-length 2,563 aa protein
- Shorter isoforms: Truncated variants expressed in specific tissues
Molecular Functions
Chromatin Remodeling Activity
CHD8 remodels chromatin through ATP-dependent nucleosome sliding and restructuring[@cotney2015]. Unlike many SWI/SNF family members, CHD8 shows particular specificity for:
- Nucleosome positioning: Shifting nucleosomes to alter transcription factor accessibility
- Chromatin decompaction: Reducing chromatin compaction to enable transcriptional activation
- Histone eviction: Facilitating removal of nucleosomes from specific genomic regions
The ATPase activity is essential for all known CHD8 functions. Mutations in the ATPase domain (particularly residues like K964 and R1240) cause complete loss of function, leading to severe neurodevelopmental phenotypes.
Transcriptional Regulation
CHD8 functions as both a direct chromatin remodeler and a transcriptional co-activator. Key mechanisms include:
Beta-catenin recruitment: CHD8 binds directly to β-catenin through a C-terminal domain and recruits it to Wnt target gene promoters[@katayama2016]. This interaction is critical for:
- Transcriptional activation of Wnt-responsive genes
- Modulation of neural progenitor cell cycle
- Regulation of cortical brain size
RNA Polymerase II modulation: CHD8 interacts with the RNA Pol II complex to regulate transcriptional elongation at target genes. It facilitates:
- Promoter-proximal pausing release
- Co-transcriptional histone modification
- mRNA processing and splicing
Enhancer targeting: CHD8 localizes to active enhancers marked by H3K27ac, where it modulates enhancer activity and regulates cell-type-specific gene expression programs[@noh2017].
Key Target Pathways
CHD8 directly regulates an extensive network of downstream targets:
Wnt/β-catenin signaling cascade:
- CTNNB1 (β-catenin itself)
- LEF1, TCF7 (transcription factors)
- AXIN2 (negative regulator)
- MYC, CCND1 (cell cycle targets)
Cell cycle and proliferation:
- CDK6, CDK4 (cyclin-dependent kinases)
- CCND1, CCND2 (cyclins)
- MCM family (DNA replication)
Neuronal development:
- NEUROD1, ASCL1 (proneural transcription factors)
- RELN (reelin signaling)
- GLI3 (Shh pathway effector)
- GAD1, SLC6A1 (synaptic proteins)
Synaptic function:
- GRIN family (NMDA receptor subunits)
- GRIK family (AMPA receptor subunits)
- DLG4 (PSD-95)
- SYN1, SYN2 (synapsins)
Brain Expression and Localization
Developmental Expression
CHD8 exhibits dynamic expression patterns during brain development:
- Embryonic stage: High expression in neural tube and cortical ventricular zone
- Mid-gestation: Peak expression in neural progenitor populations
- Late gestation: Expression shifts to post-mitotic neurons in cortical plate
Regional Distribution in Adult Brain
Based on human brain atlas data and animal studies:
- Cerebral cortex: Highest expression in layer 2/3 pyramidal neurons, moderate in layer 5/6
- Hippocampus: Strong expression in dentate gyrus granule cells and CA3 pyramidal neurons
- Cerebellum: High expression in Purkinje cells
- Striatum: Moderate expression in medium spiny neurons
- Substantia nigra: Lower expression in dopaminergic neurons
Subcellular Localization
CHD8 localizes primarily to the nucleus where it:
- Associates with open chromatin regions
- Colocalizes with RNA Pol II at active promoters
- Binds to enhancers marked by H3K27ac
Disease Associations
Autism Spectrum Disorder (ASD)
CHD8 is one of the most penetrant ASD risk genes identified to date[@bernier2014].
Mutation spectrum:
- Predominantly de novo loss-of-function variants (nonsense, frameshift, splice site)
- Missense mutations primarily affect ATPase and chromodomain regions
- No clear hotspot — mutations distributed across the coding sequence
Phenotypic features of CHD8-ASD:
- Macrocephaly (head circumference >97th percentile)
- Distinctive facial features (broad forehead, hypertelorism, flat midface)
- Intellectual disability (IQ range 40-85, average ~70)
- Gastrointestinal dysfunction (constipation, constipation-predominant IBS)
- Sleep disturbances (insomnia, irregular sleep patterns)
- Hypotonia and joint laxity
- Strong male predominance (4:1)
Mechanistic basis: CHD8 haploinsufficiency disrupts:
- Neural progenitor proliferation timing
- Cortical layer formation and neuronal migration
- Synaptic development and plasticity
- Wnt-dependent brain growth trajectories
Schizophrenia and Psychosis
Emerging evidence links CHD8 to schizophrenia risk:
- Rare deleterious variants found in schizophrenia cohorts
- Dysregulated Wnt signaling shares pathways with other schizophrenia risk genes
- Common polygenic overlap with ASD and intellectual disability
Alzheimer's Disease and Neurodegeneration
While CHD8 is not a classical Alzheimer's disease gene, several lines of evidence suggest potential roles:
Epigenetic dysregulation in AD: CHD8-mediated chromatin remodeling is among the pathways disrupted in AD brains. Loss of normal chromatin regulation contributes to:
- Altered expression of synaptic genes
- Dysregulated inflammatory responses
- Impaired neuronal resilience
Wnt signaling impairment: The Wnt/β-catenin pathway, directly modulated by CHD8, shows decreased activity in AD. Wnt signaling normally:
- Promotes neurogenesis and synaptic maintenance
- Provides anti-apoptotic protection
- Modulates amyloid processing
Chromatin remodeling factors in neurodegeneration: Studies have shown that mutations in chromatin remodelers including CHD8, CHD4, and SMARCA4 contribute to neurodevelopmental disorders with later-onset cognitive decline[@plummer2023]. The chromatin landscape in aging and AD brains shows characteristic changes including:
- Global DNA hypomethylation
- Site-specific hypermethylation at neuronal genes
- Altered histone modification patterns
Potential mechanisms linking CHD8 to neurodegeneration:
Tau pathology interactions: CHD8 regulates genes involved in cytoskeletal dynamics. Dysregulation may sensitize neurons to tau-induced toxicity.
Synaptic vulnerability: CHD8 targets many synaptic proteins. Impaired chromatin remodeling disrupts synaptic homeostasis, accelerating degeneration.
Cell cycle re-entry: CHD8 normally represses cell cycle genes in post-mitotic neurons. Loss of this regulation can trigger inappropriate cell cycle re-entry — a hallmark of dying neurons in AD.Neurodevelopmental Delay (Non-ASD)
Beyond ASD, CHD8 mutations cause:
- Global developmental delay
- Speech and language impairment (often the most affected domain)
- Motor developmental delays
- Adaptive functioning deficits
Molecular Mechanisms
Wnt/β-Catenin Signaling Dysregulation
CHD8 modulation of the Wnt pathway represents its most studied disease mechanism[@katayama2016].
Normal function: Under basal conditions, β-catenin is sequestered in a destruction complex (APC, AXIN1/2, GSK3B, CK1α). Wnt ligand binding stabilizes β-catenin, allowing it to translocate to the nucleus and co-activate transcription with TCF/LEF factors. CHD8 facilitates β-catenin recruitment to chromatin at Wnt target genes.
In CHD8 haploinsufficiency:
- Reduced β-catenin recruitment to chromatin
- Decreased Wnt target gene activation
- Altered neural progenitor proliferation rates
- Brain growth dysregulation (often leading to macrocephaly as a compensatory mechanism)
Chromatin State Alterations
CHD8 mutations cause widespread chromatin accessibility changes[@wilson2019]:
- Opening of closed chromatin: Unexpectedly, loss of CHD8 leads to chromatin decompaction at some loci, suggesting its normal role includes repressing certain enhancers.
- Compensatory chromatin remodeling: Other SWI/SNF family members (including CHD7) may partially compensate, leading to tissue-specific phenotypes.
- Developmental stage specificity: Effects are most pronounced during critical developmental windows when CHD8 is most highly expressed.
Interaction Networks
CHD8 protein-protein interactions include:
- CTNNB1 (β-catenin): Direct physical interaction via C-terminal domain
- GLI3: Regulates GLI3 processing and Shh pathway cross-talk
- REST: Co-repressor complex recruitment
- CTCF: Insulator function and chromatin looping
- RNA Pol II: Direct interaction for transcriptional co-activation
- HDAC1/2: Histone deacetylase recruitment for chromatin modulation
Therapeutic Implications
Small Molecule Approaches
Wnt pathway modulators: Given the central role of Wnt dysregulation in CHD8-related disorders:
- Wnt agonists (small molecules activating β-catenin transcriptional activity) are under investigation
- GSK3B inhibitors (e.g., tideglusib) modulate downstream Wnt targets
- Targeting specific time windows during development is critical
Epigenetic therapies:
- HDAC inhibitors may modulate downstream chromatin effects
- Bromodomain inhibitors (BET inhibitors) targeting readers of acetylated chromatin
- DNA methyltransferase inhibitors for global epigenetic correction
Gene Therapy Potential
- AAV-mediated CHD8 expression represents a potential therapeutic approach
- Delivery to critical brain regions during development windows
- Must balance expression levels — both haploinsufficiency and overexpression cause problems
Clinical Management
Current management focuses on symptomatic treatment:
- Behavioral interventions for ASD features
- GI management for constipation
- Sleep hygiene and pharmacological aids
- Early developmental support and education
Animal Models
Mouse Models
Chd8 haploinsufficiency mice:
- Recapitulate macrocephaly phenotype
- Show social behavior deficits
- Display learning and memory impairments
- exhibit abnormal cortical development
- Gene expression changes mirror human patient findings
Conditional knockout models:
- Forebrain-specific knockout reproduces cortical phenotypes
- Neural progenitor-specific knockout affects proliferation
Zebrafish Models
chd8 morpholino knockdowns cause:
- Craniofacial abnormalities
- Head size reduction
- Microcephaly (contrasting with mammalian macrocephaly — possibly due to different developmental timing)
Prognostic and Diagnostic Value
Genetic Testing
CHD8 should be included in:
- ASD gene panels (often tier 1)
- Intellectual disability gene panels
- Macrocephaly-associated gene panels
- Chromatin remodeling gene panels
Variant Interpretation
- Loss-of-function variants in coding exons are considered pathogenic
- Missense variants require functional studies for interpretation
- 3' truncating variants may represent benign variants (alternative isoform usage)
See Also
- [Chromatin Remodeling](/mechanisms/chromatin-remodeling) — broader context of chromatin factors in neurodegeneration
- [Wnt Signaling Pathway](/mechanisms/wnt-signaling-pathway) — Wnt pathway mechanisms
- [CTNNB1 Gene](/entities/ctnnb1) — β-catenin, direct interactor
- [CHD7 Gene](/genes/chd7) — related chromatin remodeler
- [Autism Spectrum Disorder](/diseases/autism-spectrum-disorder) — ASD phenotype
- [Alzheimer's Disease](/diseases/alzheimers-disease) — neurodegenerative context
- [Epigenetics in Neurodegeneration](/mechanisms/epigenetics-neurodegeneration) — chromatin-based mechanisms
External Links
- [NCBI Gene 57680](https://www.ncbi.nlm.nih.gov/gene/57680)
- [OMIM 610527](https://www.omim.org/entry/610527)
- [UniProt Q9HCK8](https://www.uniprot.org/uniprot/Q9HCK8)
- [Ensembl ENSG00000100888](https://www.ensembl.org/Human/Gene/Summary?g=ENSG00000100888)
- [GeneCards CHD8](https://www.genecards.org/cgi-bin/carddisp.pl?gene=CHD8)